FILED AND SPONSOR-REPORTED ETF HOLDINGS
JANX Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding JANX
6 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 0.69428% | 2026-01-30 (baseline) | 2026-04-30 |
| CANC | Tema Oncology ETF | 0.401743% | 2025-11-30 (baseline) | 2026-02-28 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.225737% | 2026-04-30 (baseline) | 2026-04-30 |
| FSCC | Federated Hermes MDT Small Cap Core ETF | 0.055431% | 2026-02-28 | 2026-02-28 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.009004% | 2026-01-31 (baseline) | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.001096% | 2025-12-31 (baseline) | 2026-03-31 |
Previous ETFs holding JANX
| ETF | Fund | Added / first observed | Removed / first absent |
|---|---|---|---|
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 2026-01-31 (baseline) | 2026-04-30 |